4//SEC Filing
Actinium Pharmaceuticals, Inc. 4
Accession 0001213900-17-002501
$ATNMCIK 0001388320operating
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 6:18 PM ET
Size
5.5 KB
Accession
0001213900-17-002501
Insider Transaction Report
Form 4
DAVE KAUSHIK J
DirectorPresident and CEO
Transactions
- Award
Options to purchase common stock
2017-03-14$1.39/sh+250,000$347,500→ 250,000 totalExercise: $1.39Exp: 2027-03-14→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant. In addition, 100,000 options are subject to cancellation based on the obtainment of certain milestones.
Documents
Issuer
Actinium Pharmaceuticals, Inc.
CIK 0001388320
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001388320
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 6:18 PM ET
- Size
- 5.5 KB